Hepatitis C virus (HCV) infects 170 million people worldwide; most persons who are acutely infected will develop chronic infection, while 25% of people will spontaneously clear the virus. Because of common routes of transmission, HIV-1/HCV co-infection is highly prevalent. In HIV-1/HCV co-infection, the likelihood of spontaneous clearance is worsened. While we do not fully understand the mechanisms underlying spontaneous clearance versus viral persistence, recent progress has uncovered a number of contributing factors: persons at highest risk for developing chronic HCV infection are older, male, and of African descent. The racial predisposition is partly explained by recently discovered genetic markers in the Interferon Lambda (IFNL) gene locus, which are among the most strongly predictive genetic markers of susceptibility to an infectious disease. There has been some progress in identifying the cause underlying the IFNL cluster of genes, although questions still remain. Notable defects have also been found in cytotoxic T cells and NK cells that may contribute to HCV persistence. When studying hepatitis C under the microscope, we have seen evidence of clustered infection of hepatocytes, strongly suggesting that local processes foster hepatitis C propagation.
Several clinical controversies have emerged in the management of acute HCV infection. Although public health measures have been effective at attenuating the incidence of acute HCV transmission in urban centers, there is evidence that increased rates of injection drug use in non-urban and rural settings has resulted in emerging outbreaks in these settings. There has also been evidence of outbreaks of acute HCV among HIV-1 infected men who have sex with men. With respect to treatment in the era of direct-acting antivirals, there has been discussion about whether universal treatment should be recommended: currently, AASLD/IDSA guidelines continue to support a period of monitoring patients for spontaneous clearance. However, as therapies evolve, it is likely that more patients will be treated during the acute period.